Literature DB >> 8013158

Pharmacokinetic studies in elderly people. Are they necessary?

P Crome1, R J Flanagan.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8013158     DOI： 10.2165/00003088-199426040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  14 in total

Review 1.  Drugs and the elderly.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

2.  Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in young and elderly volunteers after single and multiple dextropropoxyphene dosage.

Authors:  R J Flanagan; A Johnston; A S White; P Crome
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

Review 3.  New approaches to the use of pharmacokinetics in toxicology and drug development.

Authors:  D B Campbell; R M Ings
Journal:  Hum Toxicol       Date:  1988-09

4.  Increased sensitivity to nitrazepam in old age.

Authors:  C M Castleden; C F George; D Marcer; C Hallett
Journal:  Br Med J       Date:  1977-01-01

5.  Human pharmacokinetics of nitrazepam: effect of age and diseases.

Authors:  L Kangas; E Iisalo; J Kanto; V Lehtinen; S Pynnönen; I Ruikka; J Salminen; M Sillanpää; E Syvälahti
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

6.  Lack of effect of ageing on the stereochemical disposition of propranolol.

Authors:  H H Zhou; E Whelan; A J Wood
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

7.  Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin.

Authors:  D A Smith; M H Chandler; S I Shedlofsky; P J Wedlund; R A Blouin
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

8.  The effect of age and frailty upon acetanilide clearance in man.

Authors:  H A Wynne; L H Cope; O F James; M D Rawlins; K W Woodhouse
Journal:  Age Ageing       Date:  1989-11       Impact factor: 10.668

Review 9.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

10.  Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1980-12
View more
  7 in total

1.  Relationships among liver and kidney volumes, lean body mass and drug clearance.

Authors:  S Nawaratne; J E Brien; E Seeman; R Fabiny; J Zalcberg; W Cosolo; P Angus; D J Morgan
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

2.  Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.

Authors:  O Kozawa; T Uematsu; H Matsuno; M Niwa; S Nagashima; M Kanamaru
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 3.  Lymphadenectomy in elderly/high risk patients: should it be different?

Authors:  Laura Ruspi; Federica Galli; Vincenzo Pappalardo; Davide Inversini; Francesco Martignoni; Luigi Boni; Gianlorenzo Dionigi; Stefano Rausei
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-21

Review 4.  Geriatric oncology research to improve clinical care.

Authors:  Supriya Mohile; William Dale; Arti Hurria
Journal:  Nat Rev Clin Oncol       Date:  2012-07-24       Impact factor: 66.675

Review 5.  Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective.

Authors:  E Samara; R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

6.  Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects.

Authors:  O Kozawa; T Uematsu; H Matsuno; M Niwa; Y Takiguchi; S Matsumoto; M Minamoto; Y Niida; M Yokokawa; S Nagashima; M Kanamaru
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Protocol paper: Multi-site, cluster-randomized clinical trial for optimizing functional outcomes of older cancer survivors after chemotherapy.

Authors:  S Yilmaz; M C Janelsins; M Flannery; E Culakova; M Wells; P-J Lin; K P Loh; R Epstein; C Kamen; A S Kleckner; S A Norton; S Plumb; S Alberti; K Doyle; M Porto; M Weber; N Dukelow; A Magnuson; L A Kehoe; G Nightingale; M Jensen-Battaglia; K M Mustian; S G Mohile
Journal:  J Geriatr Oncol       Date:  2022-03-12       Impact factor: 3.929
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.